Literature DB >> 17363511

A patient perspective on brain metastases in breast cancer.

Musa Mayer.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17363511     DOI： 10.1158/1078-0432.CCR-06-2842

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  12 in total

1.  TPI-287, a new taxane family member, reduces the brain metastatic colonization of breast cancer cells.

Authors:  Daniel P Fitzgerald; David L Emerson; Yongzhen Qian; Talha Anwar; David J Liewehr; Seth M Steinberg; Sandra Silberman; Diane Palmieri; Patricia S Steeg
Journal:  Mol Cancer Ther       Date:  2012-05-23       Impact factor: 6.261

2.  Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis.

Authors:  Chenyu Zhang; Frank J Lowery; Dihua Yu
Journal:  J Vis Exp       Date:  2017-02-08       Impact factor: 1.355

Review 3.  Optimal management of brain metastases from breast cancer. Issues and considerations.

Authors:  Rupert Bartsch; Anna S Berghoff; Matthias Preusser
Journal:  CNS Drugs       Date:  2013-02       Impact factor: 5.749

Review 4.  Understanding patterns of brain metastasis in breast cancer and designing rational therapeutic strategies.

Authors:  Evelyn M Brosnan; Carey K Anders
Journal:  Ann Transl Med       Date:  2018-05

Review 5.  Preclinical approaches to study the biology and treatment of brain metastases.

Authors:  William Cruz-Muñoz; Robert S Kerbel
Journal:  Semin Cancer Biol       Date:  2010-12-13       Impact factor: 15.707

6.  Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer.

Authors:  Paul R Lockman; Rajendar K Mittapalli; Kunal S Taskar; Vinay Rudraraju; Brunilde Gril; Kaci A Bohn; Chris E Adkins; Amanda Roberts; Helen R Thorsheim; Julie A Gaasch; Suyun Huang; Diane Palmieri; Patricia S Steeg; Quentin R Smith
Journal:  Clin Cancer Res       Date:  2010-09-09       Impact factor: 12.531

7.  Roles for endothelin receptor B and BCL2A1 in spontaneous CNS metastasis of melanoma.

Authors:  William Cruz-Muñoz; Maria L Jaramillo; Shan Man; Ping Xu; Myriam Banville; Catherine Collins; Andre Nantel; Giulio Francia; Sherif S Morgan; Lee D Cranmer; Maureen D O'Connor-McCourt; Robert S Kerbel
Journal:  Cancer Res       Date:  2012-08-03       Impact factor: 12.701

Review 8.  Current therapeutic options for breast cancer central nervous system metastases.

Authors:  M Brian Hemphill; Julia A Lawrence
Journal:  Curr Treat Options Oncol       Date:  2008-04-05

9.  Microenvironment determinants of brain metastasis.

Authors:  Chenyu Zhang; Dihua Yu
Journal:  Cell Biosci       Date:  2011-02-25       Impact factor: 7.133

10.  Effect of age and biological subtype on the risk and timing of brain metastasis in breast cancer patients.

Authors:  Man-Hsin Hung; Chun-Yu Liu; Cheng-Ying Shiau; Chin-Yi Hsu; Yi-Fang Tsai; Yu-Ling Wang; Ling-Chen Tai; Kuang-Liang King; Ta-Chung Chao; Jen-Hwey Chiu; Cheng-Hsi Su; Su-Shun Lo; Cheng-Hwai Tzeng; Yi-Ming Shyr; Ling-Ming Tseng
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.